Dubai, UAE -- (SBWIRE) -- 05/21/2012 -- In keeping with its steadfast commitment towards enhancing the quality of healthcare practices in the Middle East and North Africa (MENA), Medogy has recently partnered with Pharma Quality Europe (PQE), a comprehensive quality solutions provider headquartered in Italy, specialized in rendering complete quality, validation and engineering design services in the domain of life sciences and pharmaceuticals.
This collaboration comes as the latest in a series of successful and productive alliances concluded by Medogy, and aimed at advancing medical practices, improving patient outcomes and bolstering the quality of healthcare in the region. It enables PQE to extend its quality one-stop services to MENA, thereby assisting pharmaceutical manufacturers, distributors, medical and research laboratories meet rigorous industry standards, particularly in the areas of engineering design and validation services.
“We are excited about teaming up with one of the most renowned quality service providers in Europe; indeed the World,” said Mr. Issam Marzouqa, Founding Partner & CEO at Medogy. “We very much look forward to rendering an even more diversified portfolio to the healthcare sector, and strongly believe in continuing our legacy of raising the standards to comply with Good Manufacturing Practice (GDP), Good Distribution Practice (GDP), Good Laboratory Practice (GLP), and Good Clinical Practice (GCP) in the MENA region.”
Manufacturers looking to export their products to the MENA region, the United States or Europe are required to comply with stringent requirements based on standards set by the likes of U.S. Food and Drug Administration and the European Union regulators. They can now do so, thanks to this partnership, which allows PQE to render its quality services through Medogy.
“This constitutes a valuable opportunity for PQE to continue doing what it has excelled at,” stated Mr. Francesco Amorosi, General Manager, PQE, “namely bringing effective and innovative know-how, technologies and capabilities to leading players in the life sciences industry across the globe. We are pleased to collaborate with Medogy in fulfilling this objective and hope that this partnership meets with every success.”
GMP and GDP have become legislated as mandatory practices in many countries around the world today, and constitute a series of general principles that must be maintained throughout the manufacturing and distribution process of medications and medical devices. They are centered on the concepts of safeguarding the health of individuals and upholding the standards of pharmaceutical products.